Loading...
Loading...
Among the 2 tracked institutional investors we monitor, ADIL (ADIAL PHARMACEUTICALS INC) is held with a combined value of $76.42K across 29,851 shares. The largest holder is CITADEL ADVISORS LLC with a position worth $75.64K. CITADEL ADVISORS LLC opened a new position in the most recent quarter. 1 fund reduced its position.
Total Institutional Value
$76.42K
Total Shares Held
29,851
Institutional Holders
2
Ranked by estimated dollars moved (share change × implied price). 13F data lags up to 45 days.
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | CITADEL ADVISORS LLC | $75.64K | 0.00% | New |
| 2 | BlackRock, Inc. | $778 | 0.00% | -72.6% |
As of the latest SEC 13F filings, CITADEL ADVISORS LLC is the largest institutional holder of ADIL with a position worth $75.64K, representing 0.00% of their portfolio. In total, 2 institutional investors hold ADIL with a combined value of $76.42K.
In the most recent quarter, 1 fund opened a new position in ADIL. Additionally, 1 reduced their positions.
Institutional investors hold $76.42K worth of ADIL stock across 2 positions. The largest institutional holder is CITADEL ADVISORS LLC with $75.64K in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For ADIL, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their ADIL positions.
| 2026-06-24 |
SEC Schedule 13D (activist) and 13G (passive) filings for ADIL. Filed when an investor acquires 5%+ ownership.
Last Close
$6.21
2026-08-21
YTD
+3.9%
53% of 52-week range